Kenneth Chien - Co-Founder @ Moderna - Crunchbase Person Profile

Start Free Trial

Overview

Number of Portfolio Companies

Number of Current Board & Advisor Roles

Primary Job Title Co-Founder
Primary Organization
Moderna

Location United States, North America
Gender Male
Also Known As Kenneth R. Chien, Dr. Kenneth Chien

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn
X (Twitter) View on X

Kenneth Chien is the Co-Founder of Moderna Therapeutics.

Personal Investments

Number of Investments

has made

investments. Their latest investment was

Series B - etherna immunotherapies

on

obfuscation

, when

etherna immunotherapies

raised

obfuscation

.

Announced Date	Organization Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	etherna immunotherapies	—	Series B - etherna immunotherapies	obfuscated obfuscation
obfuscated obfuscation	SmartCella	—	Funding Round - SmartCella	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

has

current jobs including

Director

at

Karolinska Institutet

,

Co-Founder

at

, and

Co-Founder, Institute of Molecular Medicine

at

Peking University

. Additionally,

has had

past job as the

Founder

at

.

Karolinska Institutet Director2013
Moderna Co-Founder2010
Peking University Co-Founder, Institute of Molecular Medicine2004

Organization Name	Title At Company	Start Date	End Date
SmartCella	Founder	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

holds

board and advisor roles including

Chairman of the Scientific Advisory Board

at

,

Advisor

at

, and

Board Member

at

etherna immunotherapies

.

Aldevron Chairman of the Scientific Advisory Board2021
EQT Advisor2020
etherna immunotherapies Board Member

Related Hubs

Hub Name	CB Rank (Hub)
Rubius Therapeutics Alumni Founded Companies	98,813
Therapeutics Companies With More Than $100M in Revenue	48,697
DFO Management Portfolio Companies	90,297
Applera Corporation Alumni Founded Companies	98,781
Pharmaceutical Public Companies With More Than $50M in Revenue	47,888
Therapeutics Public Companies	58,777
Pharmaceutical Companies With More Than $100M in Revenue	18,130
Health Care Public Companies With More Than $500 in Revenue	50,110
Ensemble Therapeutics Alumni Founded Companies	98,779
ArrowMark Partners Portfolio Companies	90,018

Education

studied at

Harvard University

and

Temple University

.

Harvard University
Temple University PhD, MD

Recent News and Activity

Number of News Articles

Funding Round•

Aug 23, 2022

etherna immunotherapies raised

obfuscation

from EQT Life Sciences and 6 other investors

Discover more funding rounds

News•

Nov 15, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 15, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Nov 10, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

Funding Round•

Sep 27, 2021

SmartCella raised

obfuscation

from AltoCumulus and 5 other investors

Discover more funding rounds

News•

Sep 27, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Sep 24, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 28, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

Jun 1, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

News•

May 24, 2021

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated